Blueshift Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21,821
Closed -$216K 490
2025
Q2
$216K Buy
+21,821
New +$230K 0.07% 373
2022
Q2
Sell
-18,059
Closed -$196K 762
2022
Q1
$196K Buy
+18,059
New +$219K 0.02% 739
2021
Q1
Sell
-41,771
Closed -$186K 895
2020
Q4
$186K Buy
+41,771
New +$189K 0.02% 631

Other funds holding DVAX

Blueshift Asset Management's DVAX Position: Q3 2025 in Review

Blueshift Asset Management sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 21,821 shares — an estimated $216K sold.

Blueshift Asset Management first reported a position in DVAX in Q4 2020 and held it in 3 quarters. The position peaked at $216K in Q2 2025. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Blueshift Asset Management reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 21,821 Dynavax Technologies shares in Q3 2025, an estimated $216K.
  • Blueshift Asset Management first reported a position in Dynavax Technologies in Q4 2020 and held it in 3 quarters.
  • Blueshift Asset Management's Dynavax Technologies position peaked at $216K in Q2 2025.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Blueshift Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.